Condition
Ischemic-Hypoxic Encephalopathy
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
150%
3 of 2 completed with results
Key Signals
3 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Not Yet Recruiting1
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT01192776Not ApplicableTerminated
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
NCT01793129Not ApplicableCompleted
Preemie Hypothermia for Neonatal Encephalopathy
NCT05820178Not ApplicableNot Yet Recruiting
tDCS and rTMS in Patients With Early Disorders of Consciousness
NCT00614744Not ApplicableCompleted
Late Hypothermia for Hypoxic-Ischemic Encephalopathy
NCT02676063UnknownPrimary
Long Term Prognostic of Neonatal Hypoxic Ischemic Encephalopathy With Hypothermia Treatment
Showing all 5 trials